Filing Details
- Accession Number:
- 0001493152-21-031655
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-16 06:08:03
- Reporting Period:
- 2021-12-14
- Accepted Time:
- 2021-12-16 06:08:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1799788 | Greenwich Lifesciences Inc. | GLSI | Pharmaceutical Preparations (2834) | 205473709 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806920 | Snehal Patel | C/O Greenwich Lifesciences, Inc. 3992 Bluebonnet Dr., Building 14 Stafford TX 77477 | Ceo And Cfo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-14 | 1,840 | $27.17 | 1,191,379 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
